Fresenius Medical Care

ExchangeRight REIT Completes 506(c) Conversion Following Successful Public Reporting Launch

Retrieved on: 
Wednesday, July 12, 2023
Kroger, Hobby Lobby, Uncertainty, Fresenius Medical Care, Essential, Walgreens, Walmart, Sponsor, REIT, COVID-19, CVS, COVID, Medicare, DST, Investment, Collection, Risk, Tractor Supply Company, Growth, Takeda Pharmaceutical Company, Real estate, Security (finance)

94.19% of the portfolio's annualized base rent is generated from essential businesses.

Key Points: 
  • 94.19% of the portfolio's annualized base rent is generated from essential businesses.
  • The REIT's fully identified portfolio is diversified across 943 properties, 627 markets, 16+ million square feet, 43 states, and 55 recession-resilient tenants across 16 necessity-based industries.
  • Warren Thomas, a managing partner at ExchangeRight, shared the story of the Essential Income REIT's uniquely strong track record and the investment strategy behind it.
  • Joshua Ungerecht, a managing partner at ExchangeRight, cited the Essential Income REIT's strong performance as a key reason for the offering's net inflows of investor capital.

Fresenius Medical Care appoints Martin Fischer as Chief Financial Officer

Retrieved on: 
Monday, July 10, 2023
Attention, Informatics, Fresenius Medical Care, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, Frankfurt Stock Exchange, COVID-19, Disclosure, Supervisory board, MBA, Columbia Business School, Limited partnership, Organization, Dialysis, Siemens Healthineers, Patient, Kidney, Siemens, University of Erlangen–Nuremberg, Applied science, ARE, FMS, Reutlingen University, FME, Pharmaceutical industry, Management

WALTHAM, Mass., July 10, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023. He will succeed Helen Giza who was appointed as Chief Executive Officer and Chair of the Management Board in December 2022 and continues to serve as acting Chief Financial Officer, until her successor will join. Martin Fischer will be based in Bad Homburg, Germany and will assume responsibility for the Global Finance Organization of Fresenius Medical Care. Upon effectiveness of the Company's proposed change of form from KGaA to German stock corporation, Martin Fischer will become a member of the Management Board of Fresenius Medical Care AG.

Key Points: 
  • WALTHAM, Mass., July 10, 2023 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases has appointed Martin Fischer (46) as Chief Financial Officer as of October 1, 2023.
  • Martin Fischer will be based in Bad Homburg, Germany and will assume responsibility for the Global Finance Organization of Fresenius Medical Care.
  • Upon effectiveness of the Company's proposed change of form from KGaA to German stock corporation, Martin Fischer will become a member of the Management Board of Fresenius Medical Care AG.
  • Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care Management AG, says: "With Martin Fischer's appointment, we are strengthening a vital function in the Management Board of Fresenius Medical Care.

Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com

Retrieved on: 
Friday, June 9, 2023
Health, Biotechnology, Karolinska Institute, Fresenius Medical Care, Partnership, Therapy, Urine, Takeda, Serum, Breast milk, Tears, Exosome, Liquid biopsy, Cancer, Lead, Immunity, MicroRNA, Research, Cell, Lung cancer, Biomarker, Inflammation, Regenerative medicine, Plasma, Seminal vesicles, Acquisition, MSC, Publication, DSM-IV codes, Patient, Medicine, CSF, Diagnosis, FDA, Fluid mechanics, Disease, Metastasis, Saliva, Prostate cancer, Medical device, Medical imaging, Pharmaceutical industry

The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Global Exosome Market - Market Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering.
  • To characterize the rapidly expanding exosome market, the analyst has released a 312-page global market report that explores the growing demand for exosome therapeutics, diagnostics, research tools, and manufacturing technologies.
  • The report reveals trend rate data for exosome patents, grants, scientific publications, and clinical trials.
  • It features company profiles for 118 global competitors from across the exosome marketplace.

FCPT Announces Acquisition of a Fresenius Medical Care Property for $2.6 Million

Retrieved on: 
Tuesday, June 6, 2023
Commercial Building & Real Estate, Construction & Property, REIT, Fresenius Medical Care, Acquisition, NYSE, Commercial property

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Fresenius Medical Care property for $2.6 million.

Key Points: 
  • Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Fresenius Medical Care property for $2.6 million.
  • The property is located in Georgia and is corporate-operated under a triple net lease with approximately three years of term remaining.
  • The transaction was priced at a 6.9% cap rate, exclusive of transaction costs.

National Kidney Foundation Appoints Walmart Chief Medical Officer Dr. Wigneswaran to National Board of Directors

Retrieved on: 
Thursday, June 1, 2023
Fresenius Medical Care, Nephrology, MBA, Tufts University School of Medicine, Massachusetts Institute of Technology, Express Scripts, Walmart, Weill Cornell Medicine, Patient, Division, NKF, DaVita Inc., National Kidney Foundation, PBM, Management, Knowledge, Johnson & Johnson, Cornell University, National Board of Medical Examiners, Kidney disease, Safety, Nursing, Cigna

NEW YORK, June 1, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart's Chief Medical Officer, to NKF's National Board of Directors. In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute, clinical program development, innovation, and medical affairs. Dr. Wig was nominated and approved at NKF's most recent Board meeting held in March. 

Key Points: 
  • NEW YORK, June 1, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Dr. John Wigneswaran (Dr. Wig), Walmart's Chief Medical Officer, to NKF's National Board of Directors.
  • In his role at Walmart, Dr. Wig leads safety, quality, and training, the Walmart Healthcare Research Institute, clinical program development, innovation, and medical affairs.
  • Dr. Wig joined Walmart from Cigna where he served as Chief Medical Officer for Express Scripts.
  • "I'm honored to join the NKF Board of Directors and very excited to help those dealing with kidney disease in any way I can," said Dr. Wigneswaran, Chief Medical Officer at Walmart.

Hemodialysis Technology Company Diality Names Robert Funari to its Board of Directors

Retrieved on: 
Wednesday, May 31, 2023
Nursing, Medical Devices, Health, Hospitals, Health Technology, Managed Care, Fresenius Medical Care, Inc., Cardinal, Baxter International, Dialysis, Funari, Cardinal Health, Acquisition, Knowledge, Kidney disease, Management, Mail order, MD

Diality Inc. , a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors.

Key Points: 
  • Diality Inc. , a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors.
  • Funari has spent nearly 50 years in the healthcare industry in public and privately held companies, in both services and medical devices.
  • He was chairman of hemodialysis technology company NxStage Medical until its 2019 acquisition by Fresenius Medical Care.
  • “We thank Aaron for his dedicated service at Diality, and wish him well in his future endeavors,” Khawar said.

Anchor Health Properties Executes on Significant Atlanta Area Off Market Transaction of a 40,000 Square Foot MOB & Announces Phase II 40,000 Square Foot MOB Development

Retrieved on: 
Thursday, May 11, 2023
Northside Hospital, Fresenius Medical Care, Fullerton Health Group, Senior, Life, Investment, Kaum Ibu (Women's Group), Collier, Foot, Virtus Investment Partners, Tenant, MOB, Acquisition, Partner, MSA, Transwestern, Growth, Phase, Commercial property, Northside Health Careers High School, Anchor, Atlanta

Other key tenancy includes Georgia Nephrology, Palmetto Infusion, Amedisys Home Health, and Gwinnett Pediatrics.

Key Points: 
  • Other key tenancy includes Georgia Nephrology, Palmetto Infusion, Amedisys Home Health, and Gwinnett Pediatrics.
  • To optimize the strategic value in the properties, the off market transaction also includes a planned second phase development of a three story, 40,000 square foot medical office building on the adjacent outparcel.
  • As the new owner, Anchor Health Properties will provide go forward asset and property management services at each location.
  • Steve Hall, John Lopez, and Bo Stuart with Transwestern will provide leasing services for the properties going forward.

Guardant Health Announces Additions to Leadership Team

Retrieved on: 
Monday, May 8, 2023
Oncology, Health, Medical Devices, Biometrics, Health Technology, General Health, Biotechnology, Fresenius Medical Care, Quest Diagnostics, LDT, Ines, Daria (name), Eye, Illumina, Multimedia, Research, GH, Dialysis, Helmy Eltoukhy, Humboldt University of Berlin, UC, Patient, University of California, Irvine, Bachelor of Arts, Knowledge, CDX, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Management

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its leadership team with the addition of Ines Dahne-Steuber as chief operating officer and the promotion of Darya Chudova to chief technology officer.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its leadership team with the addition of Ines Dahne-Steuber as chief operating officer and the promotion of Darya Chudova to chief technology officer.
  • Prior to joining Guardant Health, she served as senior vice president of operational excellence and president of Spectra Laboratories at Fresenius Medical Care North America.
  • Darya Chudova has been with Guardant Health for eight years, most recently serving as the senior vice president of technology.
  • “We are very pleased to welcome Ines to Guardant’s leadership team.

Global Disposable Hospital Supplies Market to Grow by $21.49 Billion During 2023-2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 8, 2023
Hospitals, Health, Medical Supplies, Zimmer Biomet, Medline Industries, Smith, Research, BD (company), Cardinal Health, Fresenius Medical Care, Maharashtra University of Health Sciences, 3M, Ambu (company), Boston Scientific, Thermo Fisher Scientific, Edel SE & Co. KGaA, Stryker Corporation, Teleflex, Medtronic, Retail

This study identifies the technological advances in the healthcare industry as one of the prime reasons driving the disposable hospital supplies market growth during the next few years.

Key Points: 
  • This study identifies the technological advances in the healthcare industry as one of the prime reasons driving the disposable hospital supplies market growth during the next few years.
  • Also, rising demand for distribution through online channels and retailers and high growth potential in emerging economies will lead to sizable demand in the market.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
  • The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

DocGo Announces Strategic Mobile Health Agreement with Fresenius Medical Care

Retrieved on: 
Tuesday, April 25, 2023
Health, Technology, Hospitals, Telemedicine, Virtual Medicine, Health Insurance, Artificial Intelligence, Fresenius Medical Care, FMC, Chronic kidney disease, Patient, Nephrology, Hospital, Korea Disease Control and Prevention Agency, Attention, Nursing

DocGo (Nasdaq:DCGO), a leading provider of last-mile mobile health services, today announced it has entered into a preferred provider agreement with Fresenius Medical Care (FMC) – the largest provider of kidney dialysis treatment in the United States.

Key Points: 
  • DocGo (Nasdaq:DCGO), a leading provider of last-mile mobile health services, today announced it has entered into a preferred provider agreement with Fresenius Medical Care (FMC) – the largest provider of kidney dialysis treatment in the United States.
  • This preferred provider agreement includes remote patient monitoring, principal care management, chronic care management, and urgent care services.
  • “Our relationship with Fresenius Medical Care positions DocGo to assist nephrologists with patient treatment, while growing and offering services that enable us to do what we do best: provide proactive care that mitigates a patient’s chance of hospitalization,” said Anthony Capone, CEO of DocGo.
  • If necessary, DocGo can also dispatch urgent care services and medical transportation to patients in need of immediate attention.